Trials / Completed
CompletedNCT05558202
Turkish Version of The Lower Limb Assessment Score
Turkish Version of The Lower Limb Assessment Score : Reliability and Validity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Kutahya Health Sciences University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Hypermobility is more than normal joint laxity, mobility, and range of motion. It is characterized by increased laxity and fragility of connective tissues. Symptoms from hypermobility can begin at any age and affect women more than men. People are at higher risk than other people. It is stated that hypermobility is an important factor in orthopedic injuries and diseases. Individuals with hypermobility have more frequent orthopedic complaints and the problems are usually idiopathic and chronic. Studies have reported that proprioception and musculoskeletal reflex function may be affected independently of symptoms in hypermobile individuals. Therefore, evaluating hypermobility is very important in preventing hypermobility-related problems and injuries and developing appropriate treatment methods. Although the Beighton score is the most commonly used scoring method to determine hypermobility, it may be insufficient to determine hypermobility of the lower extremities. The Lower Limb Assessment Score (LLAS) has been reported to be one of the most appropriate scoring methods for assessing lower extremity hypermobility in the literature. The aim of this study is to adapt LLAS to Turkish and measure its validity and reliability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Turkish validity and reliability | 1. Explanation of the Turkish version of the scale. 2. Translating the Turkish version of the scale into English to ensure consistency with the original scale. 3. First application of scales to participants by two examiners separately. 4. Second application of the scales to the participants by one examiner. 5. Statistical analysis and scaling |
Timeline
- Start date
- 2022-09-30
- Primary completion
- 2022-10-30
- Completion
- 2022-12-30
- First posted
- 2022-09-28
- Last updated
- 2023-08-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05558202. Inclusion in this directory is not an endorsement.